The Official National Department of Health COVID-19 Support Service: 060 012 3456 (WhatsApp)
Find a Doctor
Where can you go?
Pre-Authorisation / 24hr Emergency
0861 11 00 33
Get peace of mind with an Affinity Health
combined plan where you benefit from
all the out-of-hospital benefits as well as
private hospitalisation cover.
Health Insurance Cover customised for both Junior and Senior citizens.
Wits Journal of Clinical Medicine – COVID-19 and the Rationale for Pharmacotherapy: A South African Perspective.
Science Magazine – Modeling infectious disease dynamics
Science Magazine – Projecting the transition dynamics of SARS-CoV-2 through the post pandemic period.
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism
Statement by president cyril ramaphosa on escalation of measures to combat covid-19 epidemic
Final lockdown regulations
J Chin Medical Association: An Overview of the Outbreak of COVID-19
Journal of Global Antimicrobial Resistance: A New Challenge
Drug Discoveries and Therapies: Discovering Drugs to Treat COVID-19
Eye Reports: Recommended Use of Chloroquine, Primaquine or Tafenoquine as Prophylaxis Against COVID-19
International Journal of Antimicrobial Agents: Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19
Journal of Diabetes: Diabetes and COVID-19
Therapeutic Application of Chloroquine in Clinical Trials for COVID-19
Bioscience Trends Advance Publication: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Chloroquine and hydroxychloroquine: Current evidence for their effectiveness in treating COVID-19
Repositioning chloroquine as an ideal antiviral prophylaxis against COVID-19 – Time is now
Monitoring Transmissibility and Mortality of COVID-19 in Europe
Journal of Critical Care: A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14–2016/17 seasons)
International Journal of Infectious Diseases: The SARS-CoV-2 outbreak: what we know
International Journal of Infectious Diseases: Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis
Science Direct: Facts and Myths – Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)